225 related articles for article (PubMed ID: 8184423)
1. Biologically based dose-response modeling in developmental toxicology: biochemical and cellular sequelae of 5-fluorouracil exposure in the developing rat.
Shuey DL; Lau C; Logsdon TR; Zucker RM; Elstein KH; Narotsky MG; Setzer RW; Kavlock RJ; Rogers JM
Toxicol Appl Pharmacol; 1994 May; 126(1):129-44. PubMed ID: 8184423
[TBL] [Abstract][Full Text] [Related]
2. Early events following maternal exposure to 5-fluorouracil lead to dysmorphology in cultured embryonic tissues.
Shuey DL; Buckalew AR; Wilke TS; Rogers JM; Abbott BD
Teratology; 1994 Dec; 50(6):379-86. PubMed ID: 7778042
[TBL] [Abstract][Full Text] [Related]
3. Biological modeling of 5-fluorouracil developmental toxicity.
Shuey DL; Setzer RW; Lau C; Zucker RM; Elstein KH; Narotsky MG; Kavlock RJ; Rogers JM
Toxicology; 1995 Sep; 102(1-2):207-13. PubMed ID: 7482555
[TBL] [Abstract][Full Text] [Related]
4. Effects of developmental stage and tissue type on embryo/fetal DNA distributions and 5-fluorouracil-induced cell-cycle perturbations.
Elstein KH; Zucker RM; Andrews JE; Ebron-McCoy M; Shuey DL; Rogers JM
Teratology; 1993 Oct; 48(4):355-63. PubMed ID: 8278935
[TBL] [Abstract][Full Text] [Related]
5. Toward a biologically based dose-response model for developmental toxicity of 5-fluorouracil in the rat: acquisition of experimental data.
Lau C; Mole ML; Copeland MF; Rogers JM; Kavlock RJ; Shuey DL; Cameron AM; Ellis DH; Logsdon TR; Merriman J; Setzer RW
Toxicol Sci; 2001 Jan; 59(1):37-48. PubMed ID: 11134542
[TBL] [Abstract][Full Text] [Related]
6. Fetal anemia following maternal exposure to 5-fluorouracil in the rat.
Shuey DL; Zucker RM; Elstein KH; Rogers JM
Teratology; 1994 Apr; 49(4):311-9. PubMed ID: 8073370
[TBL] [Abstract][Full Text] [Related]
7. Effects of 5-fluorouracil on embryonic rat palate in vitro: fusion in the absence of proliferation.
Abbott BD; Lau C; Buckalew AR; Logsdon TR; Setzer W; Zucker RM; Elstein KH; Kavlock RJ
Teratology; 1993 Jun; 47(6):541-54. PubMed ID: 8367827
[TBL] [Abstract][Full Text] [Related]
8. Utility of the murine erythroleukemic cell (MELC) in assessing mechanisms of action of DNA-active developmental toxicants: application to 5-fluorouracil.
Elstein KH; Zucker RM; Shuey DL; Lau C; Chernoff N; Rogers JM
Teratology; 1993 Jul; 48(1):75-87. PubMed ID: 7688913
[TBL] [Abstract][Full Text] [Related]
9. The in vitro embryotoxicity of 5-fluorouracil in rat embryos.
Grafton TF; Bazare JJ; Hansen DK; Sheehan DM
Teratology; 1987 Dec; 36(3):371-7. PubMed ID: 3424225
[TBL] [Abstract][Full Text] [Related]
10. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
11. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists.
Crofts F; Rohatagi S; Pino M; DeLise B; Zhang J; Nguyen M; Guittin P; Barbellion S; Brunel P; Hofmann T; Schmidt J; Wong M; Lockey P; Lerman S; Clark R
Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200
[TBL] [Abstract][Full Text] [Related]
12. Nucleoside-mediated mitigation of 5-fluorouracil-induced toxicity in synchronized murine erythroleukemic cells.
Elstein KH; Mole ML; Setzer RW; Zucker RM; Kavlock RJ; Rogers JM; Lau C
Toxicol Appl Pharmacol; 1997 Sep; 146(1):29-39. PubMed ID: 9299594
[TBL] [Abstract][Full Text] [Related]
13. The developmental toxicity of inhaled methanol in the CD-1 mouse, with quantitative dose-response modeling for estimation of benchmark doses.
Rogers JM; Mole ML; Chernoff N; Barbee BD; Turner CI; Logsdon TR; Kavlock RJ
Teratology; 1993 Mar; 47(3):175-88. PubMed ID: 8475461
[TBL] [Abstract][Full Text] [Related]
14. Different embryo-fetal toxicity effects for three VLA-4 antagonists.
Crofts F; Pino M; DeLise B; Guittin P; Barbellion S; Brunel P; Potdevin S; Bergmann B; Hofmann T; Lerman S; Clark RL
Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):55-68. PubMed ID: 15098199
[TBL] [Abstract][Full Text] [Related]
15. Toward a biologically based dose-response model for developmental toxicity of 5-fluorouracil in the rat: a mathematical construct.
Setzer RW; Lau C; Mole ML; Copeland MF; Rogers JM; Kavlock RJ
Toxicol Sci; 2001 Jan; 59(1):49-58. PubMed ID: 11134543
[TBL] [Abstract][Full Text] [Related]
16. Cyclophosphamide teratogenesis: evidence for compensatory responses to induced cellular toxicity.
Francis BM; Rogers JM; Sulik KK; Alles AJ; Elstein KH; Zucker RM; Massaro EJ; Rosen MB; Chernoff N
Teratology; 1990 Nov; 42(5):473-82. PubMed ID: 2278024
[TBL] [Abstract][Full Text] [Related]
17. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
18. The role of maternal toxicity in lovastatin-induced developmental toxicity.
Lankas GR; Cukierski MA; Wise LD
Birth Defects Res B Dev Reprod Toxicol; 2004 Jun; 71(3):111-23. PubMed ID: 15282732
[TBL] [Abstract][Full Text] [Related]
19. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
[TBL] [Abstract][Full Text] [Related]
20. Cell cycle regulation of the G0/G1 transition in 5-fluorouracil-sensitive and -resistant human colon cancer cell lines.
McGinn CJ; Pestalozzi BC; Drake JC; Glennon MC; Kunugi K; Otterson G; Allegra CJ; Johnston PG; Kinsella TJ
Cancer J; 2000; 6(4):234-42. PubMed ID: 11038143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
